Citadel Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.95M | Buy |
681,634
+271,814
| +66% | +$1.8M | ﹤0.01% | 4732 |
|
|
2025
Q4 | $3.22M | Sell |
409,820
-27,792
| -6% | -$219K | ﹤0.01% | 5045 |
|
|
2025
Q3 | $3.56M | Buy |
+437,612
| New | +$2.91M | ﹤0.01% | 4978 |
|
|
2025
Q2 | – | Sell |
-1,347,859
| Closed | -$6.18M | – | 15643 |
|
|
2025
Q1 | $7.4M | Buy |
1,347,859
+514,531
| +62% | +$2.08M | 0.01% | 3287 |
|
|
2024
Q4 | $2.82M | Buy |
+833,328
| New | +$2.68M | ﹤0.01% | 4938 |
|
|
2024
Q2 | – | Sell |
-95,348
| Closed | -$192K | – | 15660 |
|
|
2024
Q1 | $211K | Sell |
95,348
-305,229
| -76% | -$790K | ﹤0.01% | 10203 |
|
|
2023
Q4 | $941K | Buy |
400,577
+371,383
| +1,272% | +$685K | ﹤0.01% | 6795 |
|
|
2023
Q3 | $54.3K | Buy |
+29,194
| New | +$66.9K | ﹤0.01% | 11665 |
|
|
2023
Q1 | – | Sell |
-21,240
| Closed | -$26.6K | – | 15690 |
|
|
2022
Q4 | $28.2K | Sell |
21,240
-14,910
| -41% | -$21K | ﹤0.01% | 12807 |
|
|
2022
Q3 | $57K | Sell |
36,150
-52,173
| -59% | -$86.3K | ﹤0.01% | 11535 |
|
|
2022
Q2 | $136K | Sell |
88,323
-54,891
| -38% | -$116K | ﹤0.01% | 11082 |
|
|
2022
Q1 | $366K | Buy |
143,214
+28,867
| +25% | +$70.5K | ﹤0.01% | 10134 |
|
|
2021
Q4 | $335K | Buy |
114,347
+38,513
| +51% | +$83.2K | ﹤0.01% | 10684 |
|
|
2021
Q3 | $186K | Buy |
75,834
+1,592
| +2% | +$4.62K | ﹤0.01% | 12091 |
|
|
2021
Q2 | $302K | Sell |
74,242
-33,820
| -31% | -$129K | ﹤0.01% | 11261 |
|
|
2021
Q1 | $487K | Buy |
108,062
+49,265
| +84% | +$266K | ﹤0.01% | 9736 |
|
|
2020
Q4 | $289K | Buy |
58,797
+35,391
| +151% | +$177K | ﹤0.01% | 9145 |
|
|
2020
Q3 | $139K | Sell |
23,406
-8,982
| -28% | -$35.9K | ﹤0.01% | 9052 |
|
|
2020
Q2 | $86K | Buy |
+32,388
| New | +$113K | ﹤0.01% | 9077 |
|
|
2019
Q2 | – | Sell |
-29,941
| Closed | -$301K | – | 10038 |
|
|
2019
Q1 | $301K | Buy |
+29,941
| New | +$384K | ﹤0.01% | 7608 |
|
|
2018
Q3 | – | Sell |
-11,290
| Closed | -$214K | – | 9854 |
|
|
2018
Q2 | $214K | Buy |
+11,290
| New | +$219K | ﹤0.01% | 7782 |
|
Other funds holding XERS
VCM
RA
N
VPM
